Suchergebnisse - "López-Medrano, Francisco"

PubPharm (227)

31

Fidaxomicin monotherapy versus standard therapy combined with bezlotoxumab for treating patients with Clostridioides difficile infection at high risk of recurrence : a matched cohort study

enthalten in: The Journal of antimicrobial chemotherapy | 2022

von Escudero-Sanchez, R. | Muriel García, A. | García Fernández, S. | +22

32

Tocilizumab therapy in SARS-CoV-2 pneumonia : A matched retrospective cohort analysis

enthalten in: Medicina clinica | 2022

von Fernández-Ruiz, M. | López-Medrano, F. | Carretero, O. | +4

33

Tocilizumab therapy in SARS-CoV-2 pneumonia : A matched retrospective cohort analysis

enthalten in: Medicina clinica (English ed.) | 2022

von Fernández-Ruiz, M. | López-Medrano, F. | Carretero, O. | +4

34

Derivation of a score to predict infection due to multidrug-resistant Pseudomonas aeruginosa : a tool for guiding empirical antibiotic treatment

enthalten in: Journal of global antimicrobial resistance | 2022

von Hernández-Jiménez, P. | López-Medrano, F. | Fernández-Ruiz, M. | +10

35

Fluconazole versus micafungin for initial antifungal prophylaxis against Candida in pancreas transplant recipients : A comparative study of two consecutive periods

enthalten in: Mycoses | 2022

von López-Medrano, F. | Muñoz de la Espada, M. | Pérez-Jacoiste Asín, M. | +14

36

An exploratory analysis of C-X-C motif chemokine ligand 10 as a new biomarker of asymptomatic Leishmania infantum infection in solid-organ transplant recipients

enthalten in: The Journal of infection | 2022

von Carrasco-Antón, N. | Ibarra-Meneses, A. | Carrillo, E. | +5

CommentIn: J Infect. 2022 Aug;85(2):e44-e46. - PMID 35659546

37

Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2022

von San-Juan, R. | Fernández-Ruiz, M. | López-Medrano, F. | +27

38

Early Treatment with Sotrovimab for Covid-19

enthalten in: The New England journal of medicine | 2022

von Origüen, J. | Caro-Teller, J. | López-Medrano, F.

CommentOn: N Engl J Med. 2021 Nov 18;385(21):1941-1950. - PMID 34706189

39

Role of cytomegalovirus infection after kidney transplantation on the subsequent risk of atherosclerotic and thrombotic events

enthalten in: Atherosclerosis plus | 2022

von Rodríguez-Goncer, I. | Corbella, L. | Lora, D. | +13

40

A predictive score at admission for respiratory failure among hospitalized patients with confirmed 2019 Coronavirus Disease : a simple tool for a complex problem

enthalten in: Internal and emergency medicine | 2022

von Lalueza, A. | Lora-Tamayo, J. | Maestro-de la Calle, G. | +35